Dhaval Desai

Company: Iveric Bio

Job title: Chief Development Officer

Seminars:

Treatment of AMD: The Role of Complement in Disease Progression 12:00 pm

Role of complement in the progression of AMD Potential role of complement inhibition in AMDRead more

day: Day One

Panel Discussion: Future Directions for Anti-VEGF Therapies 12:10 pm

Increasing patient response rates, not just prolonging treatment duration New therapy formats (bispecifics) – how does dual-specificity open up a wide range of therapeutic applications for these multifactorial diseases? Combinatorial approaches – approaches that could potentially be used on patients currently refractory or not optimally treated with anti-VEGF-A therapy aloneRead more

day: Day One